In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

Clinical trial NCT00631072 · COMPLETED

Trial details

NCT number: NCT00631072
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2008-02-01
Primary completion: 2014-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.